Healthy volunteers test new injector for common drug
NCT ID NCT07007091
First seen Jan 04, 2026 · Last updated Jun 16, 2026 · Updated 23 times
Summary
This study tested how well risankizumab enters the body when given through an on-body injector compared to a standard prefilled syringe. It involved 260 healthy adults and measured drug levels and side effects. The goal was to see if the new injector works as well as the syringe, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Acpru /Id# 276043
Grayslake, Illinois, 60030, United States
-
Cpmi /Id# 276490
Miami, Florida, 33172, United States
-
PPD Phase I Clinic /ID# 276525
Austin, Texas, 78744, United States
-
Ppd - Las Vegas Research Unit /ID# 276565
Las Vegas, Nevada, 89113, United States
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.